Format

Send to:

Choose Destination
See comment in PubMed Commons below
World J Gastrointest Endosc. 2013 Apr 16;5(4):180-5. doi: 10.4253/wjge.v5.i4.180.

What's new about inflammatory bowel diseases in Ischemic colitis induced by the newly reformulated multicomponent weight-loss supplement Hydroxycut(®).

Author information

  • 1Muhammed Sherid, Joseph H Gaziano, Department of Internal Medicine, Division of Gastroenterology, CGH Medical Center, Sterling, IL 61071, United States.

Abstract

Ischemic colitis accounts for 6%-18% of causes of acute lower gastrointestinal bleeding. It is more often multifactorial and more common in elderly. Drugs are considered important causative agents of this disease with different mechanisms. In this paper, we describe a 37-year-old otherwise healthy female presented with sudden onset diffuse abdominal pain and bloody stool. Radiologic, colonoscopic and histopathologic findings were all consistent with ischemic colitis. Her only suspected factor was hydroxycut which she had been taking for a period of 1 mo prior to her presentation. Her condition improved uneventfully after cessation of hydroxycut, bowel rest, intravenous hydration, and antibiotics. This is a first case of ischemic colitis with clear relationship with hydroxycut use (Naranjo score of 7). Our case demonstrates the importance of questioning patients regarding the usage of dietary supplements; especially since many patients consider them safe and do not disclose their use voluntarily to their physicians. Hydroxycut has to be considered as a potential trigger for otherwise unexplained ischemic colitis.

KEYWORDS:

Colonoscopy; Gastrointestinal bleeding; Herbal; Hydroxycut; Ischemic colitis; Weight-loss supplement

PMID:
23596542
[PubMed]
PMCID:
PMC3627842
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
    Loading ...
    Write to the Help Desk